This message was sent to ##Email## January 11, 2017     Home  |   About   Subscribe  |   Archive  |   Advertise   AACR releases large public cancer gene data set Medscape The American Association for Cancer Research (AACR) has publicly released one of the largest cancer genomics data sets to date. The data set houses high-quality genetic sequencing data on 19,000 patients and covers 59 cancer types. It also includes limited clinical data and has information on almost 3,000 patients with lung cancer, more than 2,000 with breast cancer and more than 2,000 with colorectal cancer.  READ MORE    SPONSORED CONTENT Promoted by InformedDNA FAMMM syndrome may be behind man's multiple cancers Practitioners peddle unneeded genetic tests, supplements Gynecologic oncologists release genetics toolkit for patients, providers InformedDNA CMO is guided by experience as a cancer researcher and survivor Learn how you could be offering genetic counseling to your patients within the next 30 days! Click here to register for our FREE webinar   Newly discovered genetic fingerprint for prostate cancer promises to personalize treatment FierceBiotech Scientists at the University of Toronto have discovered a set of genetic mutations that they believe will help oncologists predict when men with localized prostate cancer are most at risk for seeing their disease spread after treatment. The research, published in the journal Nature, describes a genetic "fingerprint" for the 30 percent of men whose cancer is thought to be curable because it's localized to the prostate, but who go on to suffer aggressive metastasis. The researchers developed the fingerprint by investigating the tumors from 500 men diagnosed with prostate cancer, according to a press release from the university. Using DNA sequencing, they studied the primary genetic differences between the tumors from men who responded well to surgery or radiation and those from patients who didn't.  READ MORE Award nominations open ACSORG The American College of Surgeons (ACS), in association with Pfizer Inc., is accepting nominations for the 2017 Surgical Volunteerism Award(s) and Surgical Humanitarian Award. All nominations must be received by Feb. 28. Information about the awards and nominations is available online. Contact ogb@facs.org with any questions.    PRODUCT SHOWCASE Advertisement Wiley's Oncology Apps Enjoy our journals? There’s an app for those! Journals such as those from the American Cancer Society ™, Journal of Surgical Oncology, Cancer Science and more are now available for your iPad and iPhone. Sample issues and abstracts, as well as open articles, can be accessed for free. A subscription to the journal is required to read the full text. Spread of triple-negative breast cancer could be halted with existing drug Medical News Today A class of drugs already approved for the treatment of estrogen receptor-positive breast cancer may also have the potential to halt the spread of hard-to-treat, triple-negative breast cancer, a new study finds.  READ MORE AJCC Cancer Staging Manual, 8th edition The American Joint Committee on Cancer (AJCC) has released the eighth edition of its Cancer Staging Manual. This edition presents evidence‐based revisions for staging cancer for a number of organ sites and includes the rationale and rules for staging; the definitions of tumor, lymph node involvement and metastasis (TNM); stage groupings; and histologic grade. The new publication can be purchased online at www.cancerstaging.org.    SPONSORED CONTENT Promoted by Prime Oncology Patient Education Videos Treatment strategies for EGFR NSCLC Updates in Lung cancer   Delaying chemo after lung cancer surgery? Better late than never Health.com The study involved thousands of patients with non-small-cell lung cancers, which comprise about 90 percent of all lung tumors. Lung cancer remains the leading cancer killer in the United States. As the study authors explained, chemotherapy is a standard part of treatment for people who've already had surgery to treat tumors that are larger than 4 centimeters (about 1.5 inches) or that have spread to the lymph nodes.  READ MORE Researchers testing new cancer treatment Voice of America Liver cancer is the sixth most common cancer in the world, and now researchers are developing new forms of treatment. If tests show you have liver cancer, there are several ways to treat the disease. One is removing the cancerous part of the liver. The other is having doctors replace the organ through a transplant operation. Patients who get someone else's liver must take immuno-suppressant drugs the rest of their life. The drugs keep the body from rejecting the new organ. There may be serious side effects that come with taking those powerful medicines.  READ MORE .  PRODUCT SHOWCASE Doctors Without Borders Doctors Without Borders/Médecins Sans Frontières (MSF) is actively recruiting general and trauma surgeons with experience in emergency obstetrics for international missions in developing countries. Learn more. In Obamacare era, older women get more cancer screenings Reuters The number of older women in the U.S. being screened for breast cancer increased after the Affordable Care Act became law in 2010 and free preventive healthcare was guaranteed, according to a new study. Researchers also found that when the law — often referred to as Obamacare — went into effect, differences in screening rates between wealthy, well-educated older women and their less well-off peers became narrower.  READ MORE     .  SPONSOR SPOTLIGHT     Scientists gain new insights into molecular mechanisms of breast cancer development News-Medical.Net Why does breast cancer develop and why are certain patients are resistant to established therapies? Researchers from the University of Basel have gained new insights into the molecular processes in breast tissue. They identified the tumor suppressor LATS as a key player in the development and treatment of breast cancer. The journal Nature has published the results.  READ MORE Announcing the Commission on Cancer 2016-2017 cancer research paper competition for physicians-in-training CoC The Commission on Cancer is hosting a paper competition for physicians-in-training to foster the importance of oncologic research in support of its mission. Papers are due June 30, 2017.  READ MORE    TRENDING ARTICLES Missed last week's issue? See which articles your colleagues read most. Senate holds emotional vote to rename cancer bill after Joe Biden's late son, Beau (CNN) Why cancer rates are rising worldwide (CBS News) Researchers identify cause for lower-extremity overgrowths in obese patients and recommend weight loss before their operations (ACS) Tracking down one of cancer's deadliest culprits, the Ras family of genes (Newsweek) Patients prefer online forums to TV shows for peer stories about cancer (Cure) Don't be left behind. Click here to see what else you missed.   The Brief Connect with AJCC Connect with CoC Connect with NAPBC Recent Issues | Subscribe | Unsubscribe | Advertise | Web Version  Colby Horton, Vice President of Publishing, 469-420-2601 | Download media kit Ashley Whipple, Senior Content Editor, 469-420-2642 | Contribute news Disclaimer: The Brief is a digest of news selected for the Commission on Cancer (CoC) and the National Accreditation Program for Breast Centers (NAPBC), both quality programs of the American College of Surgeons, from thousands of sources by the editors of MultiBriefs, an independent organization that also manages and sells advertising. The CoC and NAPBC do not endorse any of the advertised products and services. Opinions expressed in the articles are those of the author and not of the American College of Surgeons, the CoC and the NAPBC. American College of Surgeons 633 N Saint Clair Street | Chicago, IL, 60611-3211  | 800-621-4111 | Contact Us  Learn how to add us to your safe sender list so our emails get to your inbox. 7701 Las Colinas Ridge, Ste. 800, Irving, TX 75063